Vertigo, characterized by a sensation of moving or spinning, is a prevalent symptom that often presents in clinical practice. This symptom can be indicative of various underlying conditions, both benign and severe, necessitating a comprehensive and systematic approach to diagnosis and management.
Vertigo is a subtype of dizziness, often mistaken for a disease, but it is merely a symptom. It is typically associated with disorders in the vestibular system, including the inner ear and brain. Vertigo is classified into two types: peripheral, related to problems in the inner ear, and central, connected to issues in the brain.
Effective management of vertigo begins with a thorough clinical evaluation. A detailed history taking, focusing on the onset, duration, frequency, and associated symptoms, is crucial. Physical examination, including specific vestibular tests like the Dix-Hallpike maneuver, can help differentiate between peripheral and central vertigo.
Diagnostic approaches should be tailored based on the clinical assessment. For suspected peripheral vertigo, audiometry and vestibular function tests are useful. In cases of suspected central vertigo, neuroimaging techniques such as MRI or CT scan may be required. Furthermore, blood tests can help identify metabolic causes of vertigo.
Treatment should be individualized and directed towards the underlying cause. For benign paroxysmal positional vertigo (BPPV), repositioning maneuvers are effective. Pharmacological therapy, including vestibular suppressants and antiemetics, can be used for symptomatic relief. In refractory cases, surgical interventions may be considered.
Vertigo, despite being a common symptom, can often be complex and challenging to manage. A comprehensive clinical approach, encompassing a detailed history, physical examination, appropriate diagnostic testing, and tailored treatment, is essential for effective management. Ongoing research into the pathophysiology and treatment of vertigo promises to further enhance our understanding and management of this challenging symptom.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation